Click Here To Print
Product Detail
ebc item NOTICE: This is the ProQuest Ebook Central� format of this title. What is ProQuest Ebook Central�?
Other formats: Hardcover All Formats

Current Trends in Monoclonal Antibody Development and Manufacturing
Shire, Steven J.
Current Trends in Monoclonal Antibody Development and Manufacturing Cover Image
Pricing & Availability
Available: Yes*
This title does not qualify for any discount.


Other formats:
Book Information
Edition: 1st
Publisher: Springer Nature
ISBN: 0-387-76643-X (038776643X)
ISBN-13: 978-0-387-76643-0 (9780387766430)
Binding: E E Book + ProQuest Ebook Central
Copyright: 2010
Publish Date: 01/10
Weight: 0.00 Lbs.
Subject Class: PRM (Pharmacology)
Return Policy: Non-Returnable.
Table Of Contents: View
   
ProQuest Ebook Central�: eBook Please sign in to preview this title
 
Class Specifications
ISSN Series: Biotechnology: Pharmaceutical Aspects
Discipline: Micro/Immuno
Subject Definition: Antibodies, Monoclonal
NLM Class: QW 575.5
LC Class: QP905
Abstract: Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.
* Subject to ProQuest Ebook Central� availability
close

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2025 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement